Abstract:Methionine S-adenosyltransferase 2A (MAT2A) is the catalytic subunit for synthesis of S-adenosylmethionine (SAM), the principal methyl donor in many biological processes. MAT2A is up-regulated in many cancers, including liver cancer and colorectal cancer (CRC) and is a potentially important drug target. In normal liver, methionine S-adenosyltransferase 1 (MAT1), but not MAT2A is expressed. MAT2A is induced in liver cancer. We developed a family of fluorinated N,N-dialkylaminostilbene agents, called FIDAS agents, that inhibit the proliferation of CRC cells and liver cells in vitro and in vivo. Using a biotinylated FIDAS analog, we identified the catalytic subunit of MAT2A as the direct and exclusive binding target of these FIDAS agents. FIDAS agents do not bind MAT1A. MAT2B, an associated regulatory subunit of MAT2A, binds indirectly to FIDAS agents through its association with MAT2A. FIDAS agents inhibited MAT2A activity in SAM synthesis, and depletion of MAT2A by shRNAs inhibited CRC and liver cancer cell growth. FIDAS agents also inhibited specific histone methylation and repressed transcription of c-myc and other oncogenes. FIDAS agents delivered orally repressed CRC xenografts in athymic nude mice. Based on SAR and docking studies, new generations of FIDAS agents were synthesized and tested. An active in vivo metabolite of FIDAS was identified. PK/PD studies were performed. Our findings suggest that FIDAS analogs targeting MAT2A represent a family of novel and potentially useful agents for cancer treatment. Citation Format: Wen Zhang, Vitaliy Sviripa, David Watt, Chunming Liu. Methionine S-adenosyltransferase 2A (MAT2A) inhibitors for cancer treatment. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5388. doi:10.1158/1538-7445.AM2015-5388

Identification of a Sonically Activated Degrader of Methionine Adenosyltransferase 2A by an in Silico Approach Assisted with the Hole-Electron Analysis

Precise Identification of an RNA Methyltransferase's Substrate Modification Site

Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability

Structure-Based Design and Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High Selectivity, Brain Penetration, and In Vivo Efficacy

An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating M6a Methylase and Demethylase Activities

Discovery of Novel MAT2A Inhibitors by an Allosteric Site-Compatible Fragment Growing Approach

Discovery of a PROTAC degrader for METTL3-METTL14 complex

Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition

Overview of Methionine Adenosyltransferase 2A (MAT2A) As an Anticancer Target: Structure, Function, and Inhibitors.

Identification of Methionine Adenosyltransferase with High Diastereoselectivity for Biocatalytic Synthesis of (S)-S-adenosyl-l-methionine and Exploring Its Relationship with Fluorinated Biosynthetic Pathway.

High‐Throughput Computational Investigation of Protein Electrostatics and Cavity for SAM‐Dependent Methyltransferases

Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B

High-Throughput-Methyl-Reading (HTMR) Assay: a Solution Based on Nucleotide Methyl-Binding Proteins Enables Large-Scale Screening for DNA/RNA Methyltransferases and Demethylases

Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design

Capturing Unknown Substrates Via in Situ Formation of Tightly Bound Bisubstrate Adducts: S-Adenosyl-vinthionine As a Functional Probe for AdoMet-Dependent Methyltransferases

Evaluation of DNA Methyltransferase Activity and Inhibition Via Isothermal Enzyme-Free Concatenated Hybridization Chain Reaction

Identification of Three New Compounds That Directly Target Human Serine Hydroxymethyltransferase 2.

Development of a rapid mass spectrometric method for the analysis of ten-eleven translocation enzymes

Screening and Analysis of Potential Inhibitors of SHMT2

Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning.

Abstract 5388: Methionine S-adenosyltransferase 2A (MAT2A) Inhibitors for Cancer Treatment